Best Warren Buffett Stocks To Buy Right Now

The FAANG stocks have set another record.

As earnings season comes to a close, popular technology stocks are making up a bigger piece of the pie than ever before. The FAANG block of Facebook Inc., Amazon.com Inc., Apple Inc., Netflix Inc. and Google now account for over 27 percent of the NASDAQ Composite Index, a new all-time high.

Big Bite

FAANG's now make up 27 percent of the NASDAQ, a new record

Source: Bloomberg

.chart-js { display: none; }

Friday’s jump comes on the back of Apple’s better-than-expected earnings coupled with news of Warren Buffett’s latest purchase of shares in the iPhone maker.

Best Warren Buffett Stocks To Buy Right Now: Minerva Neurosciences, Inc(NERV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Minerva Neurosciences Inc (NASDAQ: NERV) shares shot up 194 percent to $10.39 after the company revealed positive top line results from a prospective Phase IIb, 12-week, randomized, double-blind, placebo-controlled parallel clinical study evaluating the efficacy, safety and tolerability of MIN-101 in patients with negative symptoms of schizophrenia.

Best Warren Buffett Stocks To Buy Right Now: Electro Scientific Industries, Inc.(ESIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pro (EOP) portfolio newsletter has suggestedsmall cap laser-based manufacturing solutions stockElectro Scientific Industries (NASDAQ: ESIO). According tothe Company itself: Its integrated solutions allow industrial designers and process engineers to control the power of laser light to transform materials in ways that differentiate their consumer electronics, wearable devices, semiconductor circuits and high-precision components for market advantage. The Company’s laser-based manufacturing solutions feature the micro-machining industry’s highest precision and speed, and target the lowest total cost of ownership.To put that more into layman terms: Electro Scientific Industries systems enable precise engineering and testing of micron to submicron features in semiconductors, LEDs, multi-layer ceramic capacitors (MLCCs), printed circuit boards (PCBs), flex circuits and other high-value components – all of which are vital to our economy.

Best Warren Buffett Stocks To Buy Right Now: Hercules Offshore Inc.(HERO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hercules Offshore, Inc. (NASDAQ: HERO) shares dropped 46 percent to $1.05 as the company reported that it has entered into a restructuring support agreement with lenders.

  • [By Monica Gerson]

    Hercules Offshore, Inc. (NASDAQ: HERO) is estimated to post a quarterly loss at $1.79 per share on revenue of $68.65 million.

    You On Demand Holdings, Inc. (NASDAQ: YOD) is expected to report its quarterly earnings.

Best Warren Buffett Stocks To Buy Right Now: Vicon Industries Inc.(VII)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Digital Ally back to below the level it was at five years ago whiledirect competitorAxon Enterprise has outperformed along withsecurity stock Napco Security Technologies Inc (NASDAQ: NSSC), but video management software stockVicon Industries, Inc (NYSEMKT: VII) has underperformed:

Best Warren Buffett Stocks To Buy Right Now: Intellipharmaceutics International Inc.(IPCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI) shares dropped 45 percent to $1.38 as the company disclosed that a FDA panel voted against approving the company’s NDA for Rexista™ abuse-deterrent oxycodone hydrochloride extended release tablets.

Best Warren Buffett Stocks To Buy Right Now: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By William Romov]

    Currently trading at $4.52 per share, Viking Therapeutics Inc. (Nasdaq: VKTX) develops drugs to treat fatty liver disease and post-hip surgery rehabilitation. It has the highest share price of the penny stocks on our list today.

  • [By George Budwell]

    Shares of Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biotech developing treatments for endocrine and metabolic disorders,dropped by 30.1% last month,according toS&P Global Market Intelligence. What’s all the fuss about?

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By George Budwell]

    Over the past year, for example, gene therapy company uniQure N.V. (NASDAQ:QURE) and endocrine specialist Viking Therapeutics (NASDAQ:VKTX) both saw their shares skyrocket against the backdrop of a fairly weak overall market for biotech. Despite their rapid appreciation, though, these two stocks might still be incredible bargains for investors comfortable with high levels of risk. Here’s why.

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

Leave a Reply

Your email address will not be published. Required fields are marked *